The cell biology of leukocyte-mediated proteolysis

Journal of Leukocyte Biology

Volumn 65, Issue 2, 1999, Pages 137-150

  Owen, Caroline A ^a,b   Campbell, Edward J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Inflammation; Proteinase; Proteinase inhibitor

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN G; CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; CHYMASE; COLLAGENASE; GELATINASE; GELATINASE B; LEUKOCYTE ELASTASE; MATRILYSIN; PROTEINASE; STROMELYSIN; TRYPTASE; UROKINASE;

CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME LOCALIZATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0033056463     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.2.137     Document Type: Review

References (164)

1. Jenne, D. E. (1994) Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis. Am. J. Respir. Crit. Care Med. 150, 5147-5154.
2. Murphy, G., Docherty, A. J. P. (1992) The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7, 120-125.
3. Vassalli, J.-D., Sappino, A. P., Belin, D. (1991) The plasminogen activator/plasmin system. J. Clin. Invest. 88, 1067-1072.
4. Travis, J. (1988) Structure, function, and control of neutrophil proteinases, Am. J. Med. 84 (Suppl. 6A), 37-42.
5. Twumasi, D. Y., Liener, I. E. (1977) Proteases from purulent sputum. Purification and properties of the elastase and chymotrypsin-like enzymes. J. Biol. Chem. 252, 1917-1926.
6. Travis, J., Salvesen, G. S. (1983) Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709.
7. Baron, R., Neff, L., Louvard, D., Courtoy, P. J. (1985) Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100 kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 101, 2210-2222.
8. Blair, H. C., Teitelbaum, S. L., Ghiselli, R., Gluck, S. (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245, 855-857.
9. Neurath, H. (1981) Evolution of proteolytic enzymes, Science 224, 350-357.
10. 1-antitrypsin: Molecular pathology, leukocytes, and tissue damage. J. Clin. Invest. 78, 1427-1431.
11. Kramps, J. A., Rudolphus, A., Stolk, J., Willems, L. N. A., Dijkman, J. H. (1901) Role of antileukoprotease in the lung. Ann. NY Acad. Sci. 624, 97-108.
12. Sallenave, J.-M., Silva, A., Marsden, M. E., Ryle, A. P. (1993) Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am. J. Respir. Cell Mol. Biol. 8, 126-133.
13. Sinha, S., Watorek, W., Karr, S., Giles, J., Bode, W., Travis, J. (1987) Primary structure of human neutrophil elastase. Proc. Natl. Acad. Sci. USA 84, 2228-2232.
14. Salvesen, G., Farley, D., Shuman, J., Przybyla, A., Reilly, C., Travis, J. (1987) Molecular cloning of human cathepsin G: Structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26, 2289-2293.
15. Boudier, C., Holle, C., Bieth, J. G. (1981) Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J. Biol. Chem. 256, 10256-10258.
16. Reilly, C. F., Tewksbury, D. A., Schechter, N. M., Travis, J. (1982) Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257, 8619-8622.
17. Campanelli, D., Melchior, M., Fu, Y., Nakata, M., Shuman, H., Nathan, C., Gabay, J. E. (1990) Cloning of cDNA for proteinase 3: A serine protease, antibiotic, and autoantigen from human neutrophils. J. Exp. Med. 172, 1709-1715.
18. Rao, N. V., Wehner, N. G., Marshall, B. C., Gray, W. R., Gray, B. H., Hoidal, J. R. (1994) Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. J. Biol. Chem. 266, 9540-9548.
19. Jennette, J. C., Hoidal, J. R., Falk, R. J. (1990) Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75, 2263-2265.
20. Braun, M. G., Csernok, E., Gross, W. L., Muller-Hermelink, H. K. (1991) Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am. J. Pathol. 39, 831-338.
21. Falk, R. J., Terrell, R. S., Charles, L. A., Jennette, J. C. (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. USA 87, 4115-4119.
22. Charles, L., Caldas, M., Falk, R., Terrell, R., Jennette, J. C. (1991) Antibodies against granule proteins activate neutrophils in vitro. J. Leukoc. Biol. 50, 539-546.
23. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
24. Takino, T. H., Sato, H., Shinagawa, A., Seiki, M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270, 23013-23020.
25. Desrochers, P. E., Weiss, S. J. (1988) Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase. J. Clin. Invest. 81, 1646-1650.
26. Desrochers, P. E., Jeffrey, J. J., Weiss, S. J. (1991) Interstitial collagenase (matrix metalloproteinase-1) expresses serpiriase activity. J. Clin. Invest. 87, 2258-2265.
27. Woessner, J. F., Jr. (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
28. Moses, M. A. (1997) The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 15, 180-189.
29. Turk, B., Turk, V., Turk, D. (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378, 141-150.
30. Henskens, Y. M. C., Veerman, E. C. I., Nieuw Amerongen, A. V. N. (1996) Cystatins in health and disease. Biol. Chem. Hoppe-Seyler 377, 71-86.
31. Chapman, H. A., Jr., Munger, J. S., Shi, G.-P. (1994) The role of thiol proteases in tissue injury and remodeling. Am. J. Respir. Crit. Care Med. 150, S155-S159.
32. Mason, R. W., Johnson, D. A., Barren, A. J., Chapman, H. A., Jr. (1986) Elastinolytic activity of human cathepsin L. Biochem. J. 233, 925-927.
33. Shi, G. -P., Munger, J. S., Meara, J. P., Rich, D. H., Chapman, H. A. (1992) Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267, 7258-7262.
34. Szecsi, P. B. (1992) The aspartic proteases. Scand. J. Clin. Lab. Invest. 52 (Suppl. 210), 5-22.
35. Kageyama, T., Yonezawa, S., Ichinose, M., Miki, K., Moriyama, A. (1996) Potential sites for processing of the human invariant chain by cathepsins D and E. Biochem. Biophys. Res. Commun. 223, 549-553.
36. Morrison, R. I. G., Barrett, A. J., Dingle, J. T., Prior, D. (1973) Cathepsins B and D. Biochim. Biophys. Acta 302, 411-419.
37. Bieth, J. G. (1986) Elastases: Catalytic and biological properties. In Biology of Extracellular Matrix: Regulation of Matrix Accumulation (R. P. Mecham, ed.) Orlando. FL: Academic Press. 217-320.
38. Welgus, H. G., Jeffrey, J. J., Eisen, A. Z. (1981) The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256, 9511-9515.
39. Gross, J., Nagai, Y. (1965) Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc. Natl. Acad. Sci. USA 54, 1197-1204.
40. Hibbs, M. S., Hasty, K. A., Seyer, J. M., Kang, A. H., Mainardi, C. L. (1985) Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260, 2493-2500.
41. Hibbs, M. S., Hoidal, J. R., Kang, A. H. (1985) Secretion of a metalloproteinase by human alveolar macrophages which degrades gelatin and native type V collagen. J. Cell. Biol. 101, 216A.
42. Gadek, J. E., Fells, G. A., Wright, D. G., Crystal, R. G. (1980) Human neutrophil elastase functions as a type III collagen "collagenase." Biochem. Biophys. Res. Commun. 95, 1815-1822.
43. Welgus, H. G., Burgesun, R. E., Wootton, J. A. M., Minor, R. R., Fliszar, C., Jeffrey, J. J. (1985) Degradation of monomeric and fibrillar type III collagens by human skin collagenase: Kinetic constants using different animal substrates. J. Biol. Chem. 260, 1052-1059.
44. Saksela, O., Rifkin, D. B. (1988) Cell-associated plasminogen activation: Regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
45. Dewald, B., Bretz, U., Baggiolini, M. (1982) Release of gelatinase from a novel secretory compartment of human neutrophils. J. Clin. Invest. 70, 518-525.
46. Plesner, T., Ploug, M., Ellis, V., Ronne, E., Hoyer-Hansen, G., Wittrup, M., Pedersen, T. L., Tscherning, T., Dano, K., Hansen, N. E. (1994) The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 83, 808-815.
47. Campbell, E. J., Silverman, E. K., Campbell, M. A. (1989) Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143, 2961-2968.
48. Owen, C. A., Campbell, M. A., Boukedes, S. S., Campbell, E. J. (1995) Inducible binding of cathepsin G to the cell surface of neutrophils: A mechanism for mediating extracellular proteolytic activity of cathepsin G. J. Immunol. 155, 5803-5810.
49. Owen, C. A., Campbell, M. A., Boukedes, S. S., Campbell, E. J. (1997) Cytokines regulate membrane-bound leukocyte elastase on neutrophils: A novel mechanism for effector activity. Am. J. Physiol. 272. L385-L393.
50. Heiple, J. M., Ossowski, L. (1986) Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis. J. Exp. Med. 164, 826-840.
51. Senior, R. M., Campbell, E. J. (1983) Neutral proteinases from human inflammatory cells: A critical review of their role in extracellular matrix degradation. Clin. Lab. Med. 3, 645-666.
52. Kargi, H. A., Campbell, E. J., Kuhn, C., III (1990) Elastase and cathepsin G of human monocytes. Heterogeneity and subcellular localization to peroxidase-positive granules. J. Histoehem. Cytochem. 38, 1179-1186.
53. Owen, C. A., Campbell, M. A., Boukedes, S. S., Stockley, R. A., Campbell, E. J. (1994) A discrete subpopulation of human monocytes expresses a neutrophil-like pro-inflammatory (P) phenotype. Am. J. Physiol. 267, L775-L785.
54. Owen, C. A., Campbell, M. A., Boukedes, S. S., Campbell, E. J. (1994) Monocytes recruited to sites of inflammation express a distinctive pro-inflammatory (P) phenotype. Am. J. Physiol. 267, L786-L796.
55. Estreicher, A., Muhlhauser, J., Carpentier, J.-L., Orci, L., Vassalli, J.-D. (1990) The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111, 783-792.
56. Kirchheimer, J. C., Remold, H. G. (1989) Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J. Immunol. 143, 2634-2639.
57. Campbell, E. J., Cury, J. D., Lazarus, C. J., Welgus, H. G. (1987) Monocyte procollagenase and tissue inhibitor of metalloproteinases: Identification, characterization, and regulation of secretion. J. Biol. Chem. 262, 15862-15868.
58. Busiek, D. F., Ross, F. P., McDonnell, S., Murphy, G., Matrisian, L. M., Welgus, H. G. (1992) The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J. Biol. Chem. 267, 9087-9092.
59. Campbell, E. J., Cury, J. D., Shapiro, S. D., Goldberg, G. I., Welgus, H. G. (1991) Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and TIMP. J. Immunol. 146, 1286-1293.
60. Campbell, E. J., White, R. R., Senior, R. M., Rodriguez, R. J., Kuhn, C., III (1979) Receptor-mediated binding and internalization of leukocyte elastase by alveolar macrophages in vitro. J. Clin. Invest. 64, 824-833.
61. White, R. R., Janoff, A., Gordon, R., Camphell, E. J. (1982) Evidence for in vitro internalization of human leukocyte elastase by human alveolar macrophages. Am. Rev. Respir. Dis. 125, 779-781.
62. Campbell, E. J. (1982) Human leukocyte elastase, cathepsin G, and lactoferrin: A family of neutrophil granule glycoproteins which bind to an alveolar macrophage receptor. Proc. Natl. Acad. Sci. USA 79, 6941-6945.
63. Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., Haslett, C. (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83, 865-875.
64. Campbell, E. J., Wald, M. S. (1983) Hypoxic injury to human alveolar macrophages accelerates release of previously bound neutrophil elastase: Implications for lung connective tissue injury including pulmonary emphysema. Am. Rev. Respir. Dis. 127, 631-635.
65. Chapman, H. A., Jr., Bertozzi, P., Sailor, L. Z., Nusrat, A. R. (1990) Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am. J. Physiol. 259, 432-438.
66. Vassalli, J. D., Wohlwend, A., Belin, D. (1992) Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: A localized and regulated proteolytic system. Curr. Top. Microbiol. Immunol. 181, 65-86.
67. Waltz, D. A., Sailor, L. Z., Chapman, H. A. (1993) Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91, 1541-1552.
68. Davis, W. B., Fells, G. A., Sun, X.-H., Gadek, J. E., Venet, A., Crystal, R. G. (1984) Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J. Clin. Invest. 74, 269-278.
69. Meier, H. L., Schulman, E. S., Heck, L. W., MacGlashan, D., Newball, H. H., Kaplan, A. P. (1989) Release of elastase from purified human lung mast cells and basophils. Inflammation 13, 295-308.
70. Schwartz, L. B., Lewis, R. A., Seldin, D., Austin, K. F. (1981) Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126, 1290-1296.
71. Graber, B. L., Schwartz, L. B., Ramamurthy, N. S., Irani, A. M., Marchese, M. J. (1988) Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J. Immunol. 140, 3936-3942.
72. Gruber, B. L., Marchese, M. J., Suzuki, K., Schwartz, L. B., Okada, Y., Nagase, H., Ramamurthy, N. S. (1989) Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84, 1657-1662.
73. Caughey, G. H. (1994) Serine proteinases of mast cell and leukocyte granules. A league of their own. Am. J. Respir. Crit. Care Med. 150, S138-S142.
74. Smyth, M. J., O'Connor, M. D., Trapani, J. A. (1996) Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies. J. Leukoc. Biol. 60, 555-562.
75. Granelli-Peperno, A., Vassalli, J.-D., Reich, E. (1977) Secretion of plasminogen activator by human polymorphonuclear leukocytes. J. Exp. Med. 146, 1693-1706.
76. Takahashi, H., Nukiwa, T., Basset, P., Crystal, R. G. (1988) Myelomonocytic cell lineage expression of the neutrophil elastase gene. J. Biol. Chem. 263, 2543-2547.
77. Hanson, R. B., Connolly, N. L. Burnett, D., Campbell, E. J., Senior, R. M., Ley. T. J. (1990) Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J. Biol. Chem. 265, 1524-1530.
78. Gallin, J. I. (1984) Neutrophil specific granules: A fuse that ignites the inflammatory response. Clin. Res. 32, 320-328.
79. Henson, P. M., Henson, J. E., Fittschen, C., Bratton, D. L., Riches, D. W. H. (1992) Degranulation and secretion by phagocytic cells. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.) New York: Raven Press, 511-539.
80. Own, C. A., Campbell, M. A., Sannes, P. L., Boukedes, S. S., Campbell, E. J. (1995) Cell-surface-bound elastase and cathepsin G on human neutrophils. A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131, 775-789.
81. Owen, C. A., Campbell, R. J. (1998) Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Imnumol. 160, 1436-1443.
82. Csernok, E., Ernst, M., Schmitt, W., Bainton, D. F., Gross, W. L. (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95, 244-250.
83. Miles, L. A., Plow, E. F. (1987) Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb. Haemost. 58, 936-942.
84. Wahl, L. M., Corcoran, M. L. (1993) Regulation of monocyte/macrophage metalloproteinase production by cytokines. J. Periodontol. 64, 467-473.
85. Shapiro, S. D., Campbell, E. J., Kobayashi, D. K., Welgus, H. G. (1990) Immune modulation of metalloproteinase production in human macrophages. Selective suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86, 1204-1210.
86. Chatham, W. W., Heck, L. W., Blackburn, W. D. (1992) Ligand dependent release of activated neutrophil collagenase - a role for surface bound 1gG in the degradation of articular collagens. Matrix (Suppl. 1), 207-208.
87. Murphy, G., Ward, R., Gavrilovic, J., Atkinson, S. (1992) Physiological mechanisms for metalloproteinase activation. Matrix (Suppl. 1), 224-230.
88. Knauper, V., Murphy, G., Tschesche, H. (1996) Activation of human neutrophil procollageriase by stromelysin 2. Eur. J. Biochem. 235, 187-191.
89. Okumoto, T., Akaike, T., Suga, M., Tanase, S., Horie, H., Miyajima, S., Ando, M., Ichinose, Y., Maeda, H. (1997) Activation of human matrix metalloproteinases by various bacterial proteiriases. J. Biol. Chem. 272, 6059-6066.
90. Okamoto, T., Akaike, T. Nagano, T., Miyajima, S., Suga, M., Ando, M., Ichimori, K., Maeda, H. (1997) Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342, 261-274.
91. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364-368.
92. Cao, J., Rehemtulla, A., Bahou, W., Zucker, S. (1996) Membrane type matrix inetalloproteinase I activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem. 271, 30174-30180.
93. Butler, G. S., Will, H., Atkinson, S. J., Murphy, G. (1997) Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur. J. Biochem. 244, 653-657.
94. Campbell, E. J., Campbell, M. A. (1988) Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: Effects of substrate opsonization. J. Cell Biol. 106, 667-676.
95. Morrison, H. M., Campbell, M. A., Stoekley, R. A., Campbell, E. J. (1988) Low molecular weight inhibitors of human leukocyte elastase fail to prevent pericellular proteolytic activity of neutrophils in vitro. Am. Rev. Respir. Dis. 137, 207 (Abstract).
96. Rice, W. G., Weiss, S. J. (1990) Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249, 178-181.
97. Campbell, E. J., Senior, R. M., McDonald, J. A., Cox, D. L. (1982) Proteolysis by neutrophds. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. J. Clin. Invest. 70, 845-852.
98. Carp, H., Janoff, A. (1980) Inaetivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants. Exp. Lung Res. 1, 225-237.
99. Carp, H., Janoff, A. (1979) In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J. Clin. Invest. 63, 793-797.
100. 1-proteinase inhibitor in vitro. J. Clin. Invest. 66, 987-995.
101. Reddy, V. Y., Desrochers, P. E., Pizzo, S. V., Gonias, S. L., Sahakian, J. A., Levine, R. L., Weiss, S. J. (1994) Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. J. Biol. Chem. 269, 4683-1691.
102. Sires, U. I., Murphy, G., Welgus, H. G., Senior, R. M. (1994) Matrilysin is much more efficient than other metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem. Biophys. Res. Commun. 204, 613-620.
103. Desrochers, P. E., Mookhtiar, K., Van Wart, H. E., Hasty, K. A., Weiss, S. J. (1992) Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichyniotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267, 5005-5012.
104. Gronski, T. J., Jr., Martin, R. L., Kobayashi, D. K., Walsh, B. C., Holman, M. C., Huber, M., Van Wart, H. E., Shapiro, S. D. (1997) Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 272, 12189-12194.
105. 1-antitrypsin in cystic fibrosis bronchopulmonary secretions. Pediatr. Pulmonol. 7, 12-17.
106. Wu, K., Uano, T., Ihara, H., Takada, Y., Fujie, M., Shikmiori, M., Hashimoto, K., Takada, A. (1995) The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood 86, 1056-1061.
107. 1 proteinase inhibitor by thiol proteinases. Biochem. J. 163, 639-641.
108. Sponer, M., Nick, H.-P., Schnebli, H.-P. (1991) Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol. Chem. Hoppe-Seyler 372, 963-970.
109. Okada, Y., Watanabe, S., Nakanishi, I., Kishi, J., Hayakawa, T., Watorek, W. Travis, J., Nagase, H. (1988) Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 229, 157-160.
110. 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. Eur. Respir. J. 4, 40-49.
111. 1-antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann. Rheum. Dis. 50, 915-916.
112. 1-antichymotrypsin by neutrophils in arthritic joints. Arthritis Rheum. 36, 168-180.
113. 1-antitrypsin inactivation and tumor necrosis factor α concentration in the synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum. 37, 1723-1726.
114. 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. Biochem. Soc. Trans. 18, 898-899.
115. Wright, S. D., Silverstein, S. C. (1984) Phagocytosing macrophages exclude proteins from zones of contact with targets. Nature 309, 359-361.
116. Morrison, H. M., Welgus, H. G., Stockley, R. A., Burnett, D., Campbell, E. J. (1990) Inhibition of human leukocyte elastase bound to elastin: Relative ineffectiveness and two mechanisms of inhibitory activity. Am. J. Respir. Cell Mol. Biol. 2, 263-269.
117. 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem. J. 238, 269-273.
118. Damiano, V. V., Tsang, A., Kucich, U., Abrams, W. R., Rosenbloom, J., Kimbel, P., Weinbaum, G. (1986) Immunolocalization of elastase in human emphysematous lungs. J. Clin. Invest. 78, 482-493.
119. Bartholomew, J., Lowther, D. A. (1987) Receptor mediated binding of leukocyte elastase by chondrocytes. Arthritis Rheum. 30, 431-438.
120. Kawabata, K., Moore, A. R., Willoughby, D. A. (1996) Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Ann. Rheum. Dis. 55, 248-252.
121. Velvart, M., Fehr, K. (1987) Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol. Int. 7, 195-202.
122. 1-proteinase inhibitor: An in vitro model of enzyme inhibition in the joint space. Rheumatol. Int. 7, 133-138.
123. Kolev, K., Lerant, I., Tenekejiev, K., Machovich, R. (1994) Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors. J. Biol. Chem. 269, 17030-17034.
124. Knuden, B. S., Silverstein, R. L., Leung, L. L. K., Harpel, P. C., Machman, R. L. (1986) Binding of plasminogen to extracellular matrix. J. Biol. Chem. 261, 10765-10771.
125. Allan, J. A., Docherty, A. J. P., Barker, P. J., Huskisson, N. S., Reynolds, J. J., Murphy, G. (1995) Binding of gelatinases A and B to type-1 collagen and other matrix components. Biochem. J. 309, 299-306.
126. Murphy, G., Allan, J. A., Willenbrock, F., Cockett, M. I., O'Connell, J. P., Docherty, A. J. P. (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
127. Hembry, R. M., Bagga, M. R., Murphy, G., Henderson, B., Reynolds, J. J. (1993) Animal model. Rabbit models of arthritis: Immunolocalization of matrix metalloproleinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am. J. Pathol. 143, 628-642.
128. Ellis, V., Wun, T.-C., Behrendt, N. Bonne, E., Dano, K. (1990) Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J. Biol. Chem. 265, 9904-9908.
129. Meyer, K. C., Zimmerman, J. (1993) Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J. Lab. Clin. Med 121, 654-661.
130. Sepper, R., Konttinen, Y. T., Buo, L., Eklund, K. K., Lauhio, A., Sorsa, T., Tschesche, H., Aasen, A. O., Sillastu, H. (1997) Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, calhepsin G and tryptase in bronchiectasis in vitro. Eur. Respir. J. 10, 2788-2793.
131. Power, C., O'Connor, C. M., Macfarlane, D., O'Mahoney, S., Gaffney, K., Haves, J., Fitzgerald, M. X. (1994) Neutrophil collagenase in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150, 818-822.
132. Sepper, R., Konttinen, Y. T., Ding, Y., Takagi, M., Sorsa, T. (1995) Human neutrophil collagenase (MMP-8). identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 107, 1641-1647.
133. 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am. Rev. Respir. Dis. 148, 1665-1670.
134. Larbre, J. -P., Moore, A. R., Da Silva, J. A. P., Iwamura, H., Ioannou, Y., Willoughby, D. A. (1994) Direct degradation of articular cartilage by rheumatoid synovial fluid: contribution of pruteolytic enzymes. J. Rheumatol. 21, 1796-1801.
135. Nordstrom, D., Lindy, O., Konttinen, Y. T., Lauhio, A., Sorsa, T., Friman, C., Pettersson, T., Santavirta, S. (1996) Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis. Clim. Rheumatol, 15, 35-41.
136. Sorsa, T., Konttinen, Y. T., Lindy, O., Ritchlin, C., Saari, H., Suomalainen, K., Eklund, K. K., Santavirta, S. (1992) Collagenase in synovitis of rheumatoid arthritis. Semin. Arthritis Rheum. 22, 44-53.
137. Beekman, B., van El, B., Drijfhout, J. W., Ronday, H. K., TeKoppele, J. M. (1997) Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay. FEBS Lett. 418, 305-309.
138. Koolwijk, P., Miltenburg, A. M. M., van Erck, M. G. M., Oudshoom, M., Niedbala, M. J., Breedveld, F. C., van Hinsbergh, V. W. M. (1995) Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J. Rheumatol. 22, 385-393.
139. Busso, N., Peclat. V., So, A., Sappino, A.-P. (1997) Plasminogen activation in synovial tissues: Differences between normal, osteoarthntis, and rheumatoid arthritis joints. Ann. Rheum. Dis. 56, 550-557.
140. Campbell, E. J. (1986) Preventive therapy of emphysema: Lessons from the elastase model. Am. Rev. Respir. Dis. 134, 435-437.
141. Liou, T. G., Campbell, E. J. (1995) Non-isotropic enzyme-inhibitor interactions: A novel non-oxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34, 16171-16177.
142. Liou, T. G., Campbell, E. J. (1996) Quantum proteolysis resulting from release of single granules by neutrophils: A novel, non-oxidative mechanism of extracellular proteolytic activity. J. Imnmnol. 157, 2624-2631.
143. Taylor, J. C., Crawford, I. P., Hugli, T. E. (1977) Limited degradation of third component (C3) of human complement by human leukocyte elastase (HLE): Partial characterization of C3 fragments. Biochemistry 16, 3390-3396.
144. Orr, F. W., Varani, J., Kreutzer, D. L., Senior, R. M., Ward, P. A. (1979) Digestion of the fifth component of complement by leukocyte enzymes: Sequential generation of chemotactic activities for leukocytes and for tumor cells. Am. J. Pathol. 94, 75-83.
145. Elsbach, P., Weiss, J. (1992) Oxygen-independent antimicrobial systems of phagocytes. In Inflammation. Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.) New York: Raven Press, 603-636.
146. Dinarello, C. A. (1992) Role of interleukin-1 and tumor necrosis factor in systemic responses to infection and inflammation. In Inflammation: Basic Principles and Clinical Carrelates (J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.) New York: Raven Press, 211-232.
147. Scuderi, P., Nez, P. A., Duerr, M. L., Wong, B. J., Valdez, C. M. (1991) Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell. Immunol. 135, 299-313.
148. Porteu, F., Brockhaus, M., Wallach, D., Engelmann, H., Nathan, C. F. (1991) Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem. 266. 18846-18853.
149. Doring, G., Frank, F., Boudier, C., Herbert, S., Fleischer, B., Bellon, G. (1995) Cleavage of lymphocyte surface antigens CD2, CD4, and CD 8 by polymorphonuelear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 154, 4842-4850.
150. Renesto, P., Ghignard, M. (1993) Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: Consequence for the neutrophil-mediated platelet activation. Blood 82, 139-144.
151. 4 by alveolar macrophages. J. Clin. Invest. 88, 891-897.
152. Bedard, M., McClure, C. D., Schiller, N. L., Francoeur, C., Cantin, A., Denis, M. (1993) Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: Implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9, 455-462.
153. Nadel, J. A. (1991) Role of mast cell and neutrophil proteases in airway secretion. Am. Rev. Respir. Dis. 144, S48-S51.
154. Starkey, P. M., Barrett, A. J. (1976) Human cathepsin G. Catalytic and immunological properties. Biochem. J. 155, 273-278.
155. Solomon, A., Schmidt, W., Havemann, K. (1976) Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence-Jones proteins. J. Immunol. 117, 1010-1014.
156. Renesto, P., Halbwachs-Mecarelli, L., Nusbaum, P., Lesavre, P., Chignard, M. (1994) Proteinase 3. A neutrophil proteinase with activity on platelets. J. Immunol. 152, 4612-4617.
157. Bainton, D. F., Csernok, E., Ludemann, J., Gross, W. L. (1990) Ultrastructural localization in normal human PMN of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Clin. Res. 38, 347A (Abstract).
158. Dano, K., Andreanen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266.
159. Sower, L. E., Klimpel, G. R., Hanna, W., Froelich, C. J. (1996) Extracellular activities of human granzymes: I. granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell. Immunol. 171, 159-163.
160. Sower, L. E., Froelich, C. J., Allegretto, N., Rose, P. M., Hanna, W. D., Klimpel, G. R. (1996) Extracellular activities of human granzyme A: monocyte activation by granzyme A versus α-thrombin. J. Immunol. 156, 2585-2590.
161. Diekmann, O., Tschesche, H. (1994) Degradation of kinins, angiotensins and substance P by polymorphonuelear matrix metalloproteinases MMP 8 and MMP 9. Braz. J. Med. Biol. Res. 27, 1865-1876.
162. Murphy, G., Cockett, M. I., Ward, R. V., Docherty, A. J. P. (1991) Matrix
163. Campbell, E. J., Senior, R. M. (1992) Update: Pulmonary Diseases and Disorders (A. P. Fishman, ed.) New York: McGraw-Hill, 37-51.
164. Campbell, E. J., Senior, R. M., Welgus, H. G. (1987) Extracellular matrix injury during lung inflammation. Chest 92, 161-167.